Adelson M D, Graves W L, Osborne N G
Department of Obstetrics and Gynecology, State University of New York, Syracuse 13210.
J Natl Med Assoc. 1992 Jan;84(1):73-5.
Pregnant patients with symptomatic and asymptomatic urinary tract infections were treated with a long and a short antibiotic regimen. Two hundred two patients were randomized prospectively to a single oral dose of 3.5 g ampicillin plus 1 g probenecid (98 patients) versus 500 mg ampicillin orally four times a day for 10 days (104 patients). The multiple-dose cure rate was statistically significantly better than that of the single-dose regimen (67.3% versus 57.1%, respectively). Interestingly, for resistant organisms, the cure rate for the long and short regimens was similar (48% versus 43%, respectively). In vitro susceptibility testing does not appear to be a good predictor of cure, at least for the single-dose group. Single-dose therapy with ampicillin and probenecid does not provide an optimal cure rate or prevent reinfection during pregnancy. Possible reasons for these findings are discussed.
有症状和无症状尿路感染的孕妇接受了长疗程和短疗程抗生素治疗。202例患者被前瞻性随机分为两组,一组口服单剂量3.5克氨苄西林加1克丙磺舒(98例患者),另一组口服500毫克氨苄西林,每日4次,共10天(104例患者)。多剂量治疗的治愈率在统计学上显著高于单剂量治疗方案(分别为67.3%和57.1%)。有趣的是,对于耐药菌,长疗程和短疗程的治愈率相似(分别为48%和43%)。体外药敏试验似乎不是治愈的良好预测指标,至少对于单剂量组是这样。氨苄西林和丙磺舒单剂量治疗不能提供最佳治愈率,也不能预防孕期再次感染。文中讨论了这些发现的可能原因。